QAM
ALXN
Quantres Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-8,800
| Closed | -$857K | – | 245 |
|
2018
Q4 | $857K | Buy |
+8,800
| New | +$857K | 0.53% | 56 |
|
2018
Q3 | – | Sell |
-10,300
| Closed | -$1.28M | – | 300 |
|
2018
Q2 | $1.28M | Sell |
10,300
-15,000
| -59% | -$1.86M | 0.74% | 42 |
|
2018
Q1 | $2.82M | Buy |
+25,300
| New | +$2.82M | 1.71% | 12 |
|
2017
Q3 | – | Sell |
-9,500
| Closed | -$1.16M | – | 257 |
|
2017
Q2 | $1.16M | Buy |
+9,500
| New | +$1.16M | 0.75% | 42 |
|
2016
Q4 | – | Sell |
-6,600
| Closed | -$809K | – | 246 |
|
2016
Q3 | $809K | Sell |
6,600
-4,600
| -41% | -$564K | 0.5% | 72 |
|
2016
Q2 | $1.31M | Buy |
+11,200
| New | +$1.31M | 0.81% | 39 |
|
2015
Q2 | – | Sell |
-4,500
| Closed | -$780K | – | 222 |
|
2015
Q1 | $780K | Buy |
4,500
+1,900
| +73% | +$329K | 0.78% | 37 |
|
2014
Q4 | $481K | Buy |
+2,600
| New | +$481K | 0.47% | 71 |
|
2014
Q3 | – | Sell |
-6,500
| Closed | -$1.02M | – | 232 |
|
2014
Q2 | $1.02M | Buy |
+6,500
| New | +$1.02M | 1.12% | 25 |
|